Oncurious


 About Oncurious NV

Oncurious NV is an oncology company focused on the development of innovative medicines for the treatment of pediatric brain tumors. Oncurious is a joint venture between ThromboGenics and VIB, a leading life science research institute in Flanders (Belgium).

Oncurious plans to initiate a Phase I/IIa clinical program with TB-403 for the treatment of medulloblastoma, a rare, life-threatening brain tumor that mainly affects children. Enrolment of the first patient is expected by the end of 2015.

BioInvent International is Oncurious’ co-development partner for the planned Phase I/IIa TB-403 clinical trial.

More information on Oncurious can be found at www.oncurious.com